Biology Technology
Dendreon Receives FDA Acknowledgement of Complete Response
| 11/20/2009 | SEATTLE, Nov. 20 Dendreon Corporation (Nasdaq: DNDN ) today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by... [Comments] |
Novavax Prices Public Offering of Common Stock
| 11/20/2009 | ROCKVILLE, Md., Nov. 20 Novavax, Inc. (Nasdaq: NVAX ) today announced that it has priced an underwritten public offering of 6,800,000 shares of its common stock at a price to the public of $3.30 per share. The approximately $21 million of net proceeds, after deducting the underwriting discounts and commissions, will be used for preclinical studies and cli... [Comments] |
Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation
| 11/20/2009 | STOCKHOLM, November 20 Karolinska Development AB todayannounced that the European Investment Fund (EIF) has entered into aco-investment agreement with the company. The co-investment fund will bemanaged by Karolinska Development and used to invest in the company'sportfolio of early-stage pharmaceutical and medical technology companies. EIFhas agreed to inve... [Comments] |
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group
| 11/20/2009 | SEATTLE, Nov. 20 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI... [Comments] |
Roller Compaction Process Optimization Using At-Line Particle Characterization
| 11/20/2009 | METTLER TOLEDO recently announced that a free webinar, “Roller Compactions Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. In this webinar, the application of in situ particle characterization is demonstrated to map the design space and optimize a series of roller compaction runs while varying raw materi... [Comments] |
Process Analytical Technology (PAT) in Green Chemistry and Green Engineering
| 11/20/2009 | METTLER TOLEDO recently announced that Dr. Dominique Hebrault will present a free webinar, “The Role of Process Analytical Technology (PAT) in Green Chemistry and Green Engineering” on December 1, 2009. (PRWEB) November 20, 2009 -- D... [Comments] |  |
Nanotube defects equal better energy and storage systems
| 11/19/2009 | Most people would like to be able to charge their cell phones and other personal electronics quickly and not too often. A recent discovery made by UC San Diego engineers could lead to carbon nanotube-based supercapacitors that could do just this. In recent research, published in Applied... [Comments] |  |
DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel
| 11/19/2009 | COPENHAGEN, Nov. 19 Danish Prince Joachim inaugurated the DONG Energy and Inbicon cellulosic ethanol plant in Kalundborg, Denmark, on Wednesday, November 18. The facility is one of the world's first and largest 2nd generation ethanol demonstration biorefineries. Genencor's Accellerase enzymes are used in the plant's innovative process for converting straw to fuel. Genen... [Comments] |
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
| 11/19/2009 | SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: OMER ) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months ended September 30, 2009, Omeros reported a net loss of $3.9 million, or $1.34 per share, as compared to a net loss of $7.4 million, or $2.54 per share, for the same period in 2008. For the nine... [Comments] |
American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
| 11/19/2009 | BLAUVELT, N.Y., Nov. 19 Dr. Mate Hidvegi, inventor of Avemar fermented wheat germ extract, responds to a press release issued on November 17 by Biropharma Kft, discrediting the Hungarian company for making false and self-serving statements about its U.S. competitor American BioSciences. Dr. Hidvegi stated from his office in Budapest, Hungary: "The Biropha... [Comments] |
(Date:11/19/2009)... of the world. It is widely used for human consump...so is considered an exemplar plant species for stu...me architecture. The authors of the research prese...cription of the B73 maize genome to probe some of ...t biology. The ten papers consider maize centromer...
(Date:11/19/2009)...-FirstCall/ -- BIO-key International, Inc. (OTC Bu...afety and finger-based biometric identification so...eting held today was adjourned without any action ..., (Logo: http://www.newscom.com/cgi-bin/prnh/2005...f the 35 million votes cast voted in favor of the ...
(Date:11/19/2009)...entists have helped identify and group the genes t... in maize, an effort that expands their ability to...for biofuels production. , The Purdue scientists...ll biology, published their findings on the 750 ce... Thursday (Nov. 19). They also were co-authors on ...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Maize cell wall genes identified, giving boost to biofuel research 2Radiologists medical physicists work to make imaging procedures safer 55558 1Radiologists medical physicists work to make imaging procedures safer 55558 2Gene variation is major genetic determinant of psoriasis 55556 1Gene variation is major genetic determinant of psoriasis 55556 2Gene variation is major genetic determinant of psoriasis 55556 3Unique study isolates DNA from Linnaeus botanical collections 9719 1...tion? Well, (as they say in the summer movies) the...sistently quiet, sudden, and deadly. Unknowingly, ...wn that rock -- you personally are not in any dang... and you may be an accomplice. , Melodrama aside,...sive, forest-destroying plant disease known as Sud...
...known that some people are biologically more susce...e only been able to speculate why. , In the Augus...esearchers at the University of Chicago report on ...hey discovered that rats most likely to self-admin... the brain that is more responsive than the same r...
...ns that bind to messenger RNA, a molecule that med...nes into proteins, triggers the appearance of frag...late-life disorder associated with the gene that c...hers from Baylor College of Medicine in Houston an...that appears today in the journal Neuron. , They ...
Other Biology News:Humans fostering forest-destroying disease 2Humans fostering forest-destroying disease 3Humans fostering forest-destroying disease 4Nicotinic receptors may be important targets for treatment of multiple addictions 2Researchers identify proteins involved in new neurodegenerative syndrome 2...LC/MS, using mass numbers as a trigger, precisely ...forming investigation and research of natural comp...tical and preparative operation. Switching between... support provides a quick solution for chemists op...
...cker Intracellular Localization Kit provides a str...er siRNA, of your design, in an efficient yet non-...nts. Subcellular localization and functional inhib...ollowing introduction of the labeled siRNA into ma...
...00 instrument can be used as a fully functional, s...r Software provides the means to record and tabula...se data can then be copied and pasted into commerc...cel or Lotus 123, or into a curve-fitting program....
... are designed for the study of protein:protein int...method. Proteins that interact with GST•Tag&...usion proteins are copurified using affinity resin...a spin filter. The complexes are eluted with sampl...
Biology Products:(Date:11/19/2009)... is honored by latest award for revolutionary hear...WEB) November 16, 2009 -- Popular Science Magazine...ng aid from InSound Medical a winner of its covete...egory. Chosen from thousand... the hearing canal for up to four months while pro...
(Date:11/18/2009)...be able to find explosive materials and persons wh...ches, the National Institute of Standards and Tech... Homeland Security, has developed a new certified ...RM) 2905, Trace Particulate Explosives. Compatible...will be helpful in calibrating, testing and develo...
(Date:11/18/2009)...e in data analysis combined with Bio-Rad,s Bio...curricula provide state-of-the-art solutions to bi.... 18 Vernier Software & Techno..., sensors, and software and Bio-Rad Laboratories, ... of life science research and clinical diagnostics...
(Date:11/18/2009)...8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NY...development company that identifies and advances a...ducts at various stages of development, announced ...ere presented today in a poster at the 2009 AACR-N... conference in Boston, Massachusetts. The reported...
Breaking Biology Technology:Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3[0] Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award[0] New NIST trace explosives standard slated for homeland security duty[0] Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education[0] YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
...heduled for Thursday, March 27TH AT 5 PM ... 20 ImaRx Therapeutics,Inc. (Nasdaq: IMRX ) toda...ast and conference call on Thursday, March 27, 200...d fourth quarter 2007 financial results., The liv...e website at, http://www.imarx.com and will be ar...
...irstCall/ - Chromos Molecular,Systems Inc. ("Chrom...tered,into a secured, convertible debenture agreem...re to be used to fund expenses associated with the...ocuments and maintaining,the integrity of the rema...erest, at 12% per annum, are due and payable on Ju...
...armAthene,s Status as a Premie...panded Biodefense Pipeline ANNAPOLIS, Md., and TE... biodefense company,specializing in the developmen... against biological and chemical threats, and Avec...iopharmaceuticals, announced,today that the compan...
Other Biology Technology:ImaRx to Report Corporate Updates and 4Q07 Financial Results 2Chromos enters into loan and lending arrangements 2PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 2PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 3PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 4PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 5PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 6| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |